Corrigendum to "Insights into the role of FGF21 in coronary heart disease" [Int. J. Biol. Macromol. (Oct 28 2024) 136911]

Affiliation

• ¹ Health Sciences Institute, China Medical University, Shenyang, China; Institute of Life Sciences, China Medical University, Shenyang, China; Liaoning Key Laboratory of Obesity and Glucose/Lipid Associated Metabolic Diseases, China Medical University, Shenyang, China. Electronic address: liuhx@cmu.edu.cn.